John Limongelli Email

Chief Legal Officer . Imvax

Current Roles

Employees:
59
Revenue:
$4.6M
About
The approach is an autologous, cell-based treatment that activates the full array of patient-specific antigens, resulting in both an innate and adaptive immune response. The company's lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer with a significant unmet need. In parallel, the company is also progressing the platform in a select number of additional solid tumors where the unmet need remains great and where initial immunotherapy approaches have often failed to provide a significant benefit.
Imvax Address
601 Walnut St
Philadelphia, PA
United States
Imvax Email

Past Companies

Imvax, Inc.Chief Legal Officer
Limongelli Legal Consulting, LLCPrincipal
Neos Therapeutics, Inc.Senior Vice President, General Counsel & Corporate Secretary

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.